RISEDRONATE WAY (Waymade Australia Pty Limited)
Product name
RISEDRONATE WAY
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
119 (255 working days)
Active ingredients
risedronate sodium hemipentahydrate
Registration type
New generic medicine
Indication
Risedronate Way is indicated for:
- Treatment of osteoporosis
- Treatment of glucocorticoid-induced osteoporosis
- Preservation of bone mineral density in patients on long term corticosteroid therapy